新型冠状病毒肺炎与心脏损伤相关性的Meta分析
Meta Analysis of the Correlation between COVID-19 and Heart Injury
DOI: 10.12677/ACM.2020.108233, PDF,   
作者: 潘小玉*:济宁医学院临床医学院,山东 济宁;济宁市第一人民医院心血管内科,山东 济宁;张再伟#:济宁市第一人民医院心血管内科,山东 济宁;济宁市第一人民医院心血管病研究所,山东 济宁;李 虎, 周中兴, 崔志远, 陈莎莎, 马 杰, 侯丽娟, 李 颖:济宁市第一人民医院心血管内科,山东 济宁
关键词: 新型冠状病毒肺炎心脏损伤合并症Meta分析COVID-19 Heart Injury Complications Meta Analysis
摘要: 目的:通过meta分析评价新型冠状病毒肺炎与心脏损伤的相关性,为临床提供循证依据。方法:计算机检索万方、知网、中国生物医学文献数据库、PubMed、Embase、Cochrane Library、Medline数据库,检索感染新型冠状病毒肺炎与心脏损伤的相关研究,检索时间区间均从2020年1月1日至2020年4月20日。对于纳入的研究,应用Rev Man5.3及STATA软件进行分析。结果:总共纳入29项研究,合计4466名患者。Meta分析结果示:危重型患者比非危重型患者有更高的肌钙蛋白(p = 0.03);合并心肌损伤的患者病情更重、死亡率更高(p = 0.002; p < 0.0001);此外,患有冠心病、糖尿病或高血压的患者感染新型冠状病毒肺炎后比普通人群感染后病情更重,死亡率更高(p < 0.01);CK-MB、AST、肌红蛋白、NT-proBNP也对判断病情严重程度有一定价值。结论:合并心脏损伤的新冠肺炎患者病情更重、死亡率更高,且患有基础疾病也能加重病情、提高死亡率。
Abstract: AIM: To evaluate the correlation between COVID-19 and heart injury through meta analysis, and to provide evidence-based basis for clinical practice. Methods: Wanfang, CNKI, Chinese biomedical literature database, PubMed, Embase, Cochrane Library, Medline database were searched by computer to retrieve studies related to COVID-19 infection and heart injury. The search time ranges from January 1, 2020 to April 20, 2020. Rev Man5.3 and STATA software were used to analyze the included studies. Results: A total of 29 studies were included, totaling 4466 patients. The results of the meta analysis showed that the critically ill patients had higher troponin than the non-critical patients (p = 0.03); the patients with myocardial injury were more serious and had higher mortality (p = 0.002; p = 0.0001); furthermore, patients with coronary heart disease, diabetes, or high blood pressure have more severe and higher mortality rates after infection with COVID-19 (p < 0.01); CK-MB, AST, MYO, NT-proBNP also had some value in judging the severity of the disease. Conclusion: The COVID-19 patients with heart injury are more serious, and have a higher mortality rate, and having basic diseases can also aggravate the condition and increase the mortality rate.
文章引用:潘小玉, 张再伟, 李虎, 周中兴, 崔志远, 陈莎莎, 马杰, 侯丽娟, 李颖. 新型冠状病毒肺炎与心脏损伤相关性的Meta分析[J]. 临床医学进展, 2020, 10(8): 1554-1565. https://doi.org/10.12677/ACM.2020.108233

参考文献

[1] Zhang, G., Hu, C., Luo, L., et al. (2020) Clinical Features and Short-Term Outcomes of 221 Patients with COVID-19 in Wuhan, China. Journal of Clinical Virology, 127, Article ID: 104364. [Google Scholar] [CrossRef] [PubMed]
[2] Metzler, B., Siostrzonek, P., Binder, R.K., et al. (2020) Decline of Acute Coronary Syndrome Admissions in Austria since the Outbreak of COVID-19: The Pandemic Response Causes Cardiac Collateral Damage. European Heart Journal, 41, 1852-1853. [Google Scholar] [CrossRef] [PubMed]
[3] Kochi, A.N., Tagliari, A.P., Forleo, G.B., et al. (2020) Cardiac and Arrhythmic Complications in Patients with COVID-19. Journal of Cardiovascular Electrophysiology, 31, 1003-1008. [Google Scholar] [CrossRef] [PubMed]
[4] Han, Y.L. (2020) Initial COVID-19 Affecting Cardiac Patients in China. European Heart Journal, 41, 1719.
[5] 彭昱东, 孟凯, 官红权, 等. 心血管病患者感染新型冠状病毒肺炎112例临床特点及转归[J/OL]. 中华心血管病杂志, 2020, 48: E004. http://rs.yiigle.com/yufabiao/1183314.htm, 2020-03-02.
[6] 刘欢, 马小峰, 谭剑凯, 黄柯, 周琴怡, 姜志胜. COVID-19重型患者心肌损伤及心脏功能变化的初步观察[J]. 中国动脉硬化杂志, 2020, 28(4): 285-289.
[7] 李美瑜, 吕明芳, 李翠芝, 童裕维, 李景隆, 雷春亮. 不同临床分型新型冠状病毒肺炎患者的心脏表现特征[J]. 广东医学, 2020, 41(8): 1-4.
[8] 李翠芝, 李美瑜, 甘露, 张影, 雷春亮. 新型冠状病毒肺炎患者合并心脏和肝脏损害的临床分析[J]. 广东医学, 2020, 41(9): 1-4.
[9] 陈晨, 陈琛, 严江涛, 等. 新型冠状病毒肺炎危重症患者心肌损伤及患有心血管基础疾病的情况分析[J/OL]. 中华心血管病杂志, 2020, 48. http://rs.yiigle.com/yufabiao/1183794.htm, 2020-03-06.
[10] 程克斌, 魏明, 沈虹, 吴超民, 陈德昌, 熊维宁, 周新, 张定宇, 郑军华. 普通型和重型新型冠状病毒肺炎康复患者463例临床特征分析[J/OL]. 上海医学, 2020: 1-15. http://kns.cnki.net/kcms/detail/31.1366.r.20200312.1254.004.html, 2020-04-22.
[11] 张权宇, 杨哲然, 李毅, 彭程飞, 于浩, 唐裕福, 滕玥, 史亮, 马壮, 韩雅玲. 新冠肺炎临床轻症患者冠心病及其危险因素临床特征总结[J/OL]. 心脏杂志, 2020, 32(2): 1-6. http://kns.cnki.net/kcms/detail/61.1268.r.20200407.0858.001.html, 2020-04-22.
[12] Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet (London, England), 395, 497-506. [Google Scholar] [CrossRef
[13] Cai, Q., Huang, D., Ou, P., et al. (2020) 2019-nCoV Pneumonia in a Normal Work Infectious Diseases Hospital Besides Hubei Province, China. https://ssrn.com/abstract=3542163 [Google Scholar] [CrossRef
[14] Ji, D., Zhang, D., Chen, Z., et al. (2020) Clinical Characteristics Predicting Progression of COVID-19. https://ssrn.com/abstract=3539674 [Google Scholar] [CrossRef
[15] Lu, H., Ai, J., Shen, Y., et al. (2020) A Descriptive Study of the Impact of Diseases Control and Prevention on the Epidemics Dynamics and Clinical Features of SARS-CoV-2 Outbreak in Shanghai, Lessons Learned for Metropolis Epidemics Prevention. [Google Scholar] [CrossRef
[16] Wang, D., Hu, B., Hu, C., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. [Google Scholar] [CrossRef] [PubMed]
[17] Zhou, B., She, J., Wang, Y., et al. (2020) The Clinical Characteristics of Myocardial Injury in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease. Journal of Infection, 81, 147-178. https://ssrn.com/abstract=3539668 [Google Scholar] [CrossRef
[18] Wang, G., Wu, C., Zhang, Q., et al. (2020) Epidemiological and Clinical Features of Corona Virus Disease 2019 (COVID-19) in Changsha, China. https://ssrn.com/abstract=3548770 [Google Scholar] [CrossRef
[19] Wan, S., Xiang, Y., Fang, W., et al. (2020) Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing. Journal of Medical Virology, 92, 797-806. [Google Scholar] [CrossRef] [PubMed]
[20] Han, Y., Zhang, H., Mu, S., et al. (2020) Lactate Dehydrogenase, a Risk Factor of Severe COVID-19 Patients. [Google Scholar] [CrossRef
[21] Ma, K., Liu, Z., Cao, C., et al. (2020) COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study. [Google Scholar] [CrossRef
[22] 王朗, 何文博, 余小梅, 等. 心肌损伤对新型冠状病毒肺炎患者临床预后的影响[J/OL]. 中华心血管病杂志, 2020, 48. http://rs.yiigle.com/yufabiao/1188751.htm, 2020-04-14.
[23] 贺行巍, 赖金胜, 程佳, 等. 重型/危重型新型冠状病毒肺炎患者合并心肌损伤对预后的影响[J/OL]. 中华心血管病杂志, 2020, 48. http://rs.yiigle.com/yufabiao/1184840.htm, 2020-03-15.
[24] Yang, X., Yu, Y., Xu, J., et al. (2020) Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8, 475-481. [Google Scholar] [CrossRef
[25] Zhou, F., Yu, T., Du, R., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. The Lancet (London, England), 395, 1054-1062. [Google Scholar] [CrossRef
[26] Fu, L., Fei, J., Xiang, H., et al. (2020) Influence Factors of Death Risk among COVID-19 Patients in Wuhan, China: A Hospital-Based Case-Cohort Study. [Google Scholar] [CrossRef
[27] Ruan, Q., Yang, K., Wang, W., et al. (2020) Correction to: Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China. Intensive Care Medicine. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, T., Wu, D., Chen, H., et al. (2020) Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ (Clinical Research ed.), 368, m1091. [Google Scholar] [CrossRef] [PubMed]
[29] Zhang, F., Yang, D., Li, J., et al. (2020) Myocardial Injury Is Associated with In-Hospital Mortality of Confirmed or Suspected COVID-19 in Wuhan, China: A Single Center Retrospective Cohort Study. [Google Scholar] [CrossRef
[30] Liu, Y., Li, J., Liu, D., et al. (2020) Clinical Features and Outcomes of 2019 Novel Coronavirus-Infected Patients with Cardiac Injury. [Google Scholar] [CrossRef
[31] Shi, S., Qin, M., Shen, B., et al. (2020) Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. [Google Scholar] [CrossRef] [PubMed]
[32] Guo, T., Fan, Y., Chen, M., et al. (2020) Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 811-818. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, J., Fan, H., Zhang, L., et al. (2020) Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19. [Google Scholar] [CrossRef
[34] Xu, X., Chen, P., Wang, J., et al. (2020) Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of Its Spike Protein for Risk of Human Transmission. Science China Life Sciences, 63, 457-460. [Google Scholar] [CrossRef] [PubMed]
[35] Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513. [Google Scholar] [CrossRef
[36] Hui, H., Yang, H., Wang, X., et al. (2020) Clinical and Radiographic Features of Cardiac Injury in Patients with 2019 Novel Coronavirus Pneumonia. [Google Scholar] [CrossRef